Targeting DNA repair pathway in cancer: Mechanisms and clinical application

M Wang, S Chen, D Ao - MedComm, 2021 - Wiley Online Library
Over the last decades, the growing understanding on DNA damage response (DDR)
pathways has broadened the therapeutic landscape in oncology. It is becoming increasingly …

DNA damage signalling and repair inhibitors: the long-sought-after Achilles' heel of cancer

D Velic, AM Couturier, MT Ferreira, A Rodrigue… - Biomolecules, 2015 - mdpi.com
For decades, radiotherapy and chemotherapy were the two only approaches exploiting DNA
repair processes to fight against cancer. Nowadays, cancer therapeutics can be a major …

Phosphatidylinositol 3-kinase (PI3K) and phosphatidylinositol 3-kinase-related kinase (PIKK) inhibitors: importance of the morpholine ring

M Andrs, J Korabecny, D Jun, Z Hodny… - Journal of medicinal …, 2015 - ACS Publications
Phosphatidylinositol 3-kinases (PI3Ks) and phosphatidylinositol 3-kinase-related protein
kinases (PIKKs) are two related families of kinases that play key roles in regulation of cell …

[HTML][HTML] DNA-PK in human malignant disorders: Mechanisms and implications for pharmacological interventions

M Medová, M Medo, L Hovhannisyan… - Pharmacology & …, 2020 - Elsevier
The DNA-PK holoenzyme is a fundamental element of the DNA damage response
machinery (DDR), which is responsible for cellular genomic stability. Consequently, and …

Phytochemicals: potential therapeutic modulators of radiation induced signaling pathways

BP Jit, B Pradhan, R Dash, PP Bhuyan, C Behera… - Antioxidants, 2021 - mdpi.com
Ionizing radiation results in extensive damage to biological systems. The massive amount of
ionizing radiation from nuclear accidents, radiation therapy (RT), space exploration, and the …

Inactivation of DNA-PK by knockdown DNA-PKcs or NU7441 impairs non-homologous end-joining of radiation-induced double strand break repair

J Dong, Y Ren, T Zhang, Z Wang… - Oncology …, 2018 - spandidos-publications.com
The DNA-dependent protein kinase (DNA-PK) complex plays a pivotal role in non-
homologous end-joining (NHEJ) repair. We investigated the mechanism of NU7441, a …

Combined ATR and DNA-PK inhibition radiosensitizes tumor cells independently of their p53 status

H Hafsi, MT Dillon, HE Barker, JN Kyula… - Frontiers in …, 2018 - frontiersin.org
Head and neck squamous cell carcinoma (HNSCC) is a significant cause of cancer deaths.
Cisplatin-based chemoradiotherapy is a standard of care for locally advanced disease. ATR …

[HTML][HTML] NU7441 enhances the radiosensitivity of liver cancer cells

C Yang, Q Wang, X Liu, X Cheng, X Jiang… - Cellular Physiology and …, 2016 - karger.com
Objective: Radiation therapy, one of the major treatments for liver cancer, causes DNA
damage and cell death. Since the liver cancer cells have a strong capacity to repair …

[PDF][PDF] Small molecule inhibitors of DNA-PK for tumor sensitization to anticancer therapy

M Pospisilova, M Seifrtova, M Rezacova - J Physiol Pharmacol, 2017 - jpp.krakow.pl
The most sensitive cell structure-a DNA molecule, is the common target of cancer therapy.
DNA damage response (controlled by enzymes from the phosphatidylinositol 3-kinase …

Preventing damage limitation: targeting DNA-PKcs and DNA double-strand break repair pathways for ovarian cancer therapy

DA Dungl, EN Maginn, EA Stronach - Frontiers in Oncology, 2015 - frontiersin.org
Platinum-based chemotherapy is the cornerstone of ovarian cancer treatment, and its
efficacy is dependent on the generation of DNA damage, with subsequent induction of …